Study summary

The purpose of this study was to investigate a medicine for the treatment of symptoms and complications of neurogenic detrusor overactivity (NDO) in children and adolescents.

Additional Study Details

Phase
3
Product
N/A
Product
Solifenacin succinate
Type
Interventional
Masking
None (Open Label)
Enrollment number
76
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A study to assess the long term effect, safety and metabolism of a solifenacin liquid suspension in participants 5 to 18 years of age with neurogenic detrusor overactivity? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Withdrawn
    Site RU7002
    Moscow, Russian Federation, 123317
    Withdrawn
    Site CA1005
    Hamilton, ON, Canada, L8N 3Z5
    Withdrawn
    Site RU7001
    Saint Petersburg, Russian Federation, 194100
    Withdrawn
    Site FR3301
    Paris, France, 75015
    Completed
    Site BE3201
    Gent, Belgium, 9000
    Terminated
    Site PL4805
    Gdansk, Poland, 80803
    Withdrawn
    Site DE4905
    Mainz, Germany, 55101
    Completed
    Site PH6302
    Quezon City, Philippines, 1101
    Withdrawn
    Site IN9115
    Pune, India, 411040
    Completed
    Site BR5505
    Sao Jose do Rio Preto, São Paulo, Brazil, 15090-000
    Terminated
    Site HU3602
    Miskolc, Hungary, 3526
    Withdrawn
    Site IN9104
    Dehradun, India, 248140
    Withdrawn
    Site DE4903
    Bonn, Germany, 53105
    Withdrawn
    Site RU7003
    Saint Petersburg, Russian Federation, 194100
    Withdrawn
    Site NL3103
    Rotterdam, Netherlands, 3015 GJ
    Withdrawn
    Site GB4403
    Leeds, United Kingdom, LS17RFJ
    Withdrawn
    Site NL3104
    Zwolle, Netherlands, 8011 JW
    Completed
    Site MX5205
    Mexico City, Mexico, C.P. 06700
    Completed
    Site TR9002
    Izmir, Turkey, 35100
    Completed
    Site BR5506
    Curitiba, Brazil, 80240-060
    Withdrawn
    Site PL4802
    Wroclaw, Poland, 50-369
    Completed
    Site BR5504
    Campinas, Brazil, 13083-887
    Completed
    Site US1010
    Cincinnati, OH, United States, 45229-3039
    Withdrawn
    Site US1007
    Stanford, CA, United States, 94305
    Completed
    Site BR5507
    Campinas, Brazil, 13060-803
    Completed
    Site BR5503
    Porto Alegre, Brazil, 90035-903
    Withdrawn
    Site GB4402
    Stanmore, United Kingdom, HA7 4LP
    Withdrawn
    Site FR3302
    Lille, France, 59037
    Completed
    Site KR8201
    Seoul, Republic of Korea, 120752
    Completed
    Site KR8207
    Seoul, Republic of Korea, 110744
    Withdrawn
    Site GB4401
    Sheffield, South Yorkshire, United Kingdom, S10 2TH
    Withdrawn
    Site BR5502
    Sao Paulo, Brazil, 05403-000
    Completed
    Site PH6301
    Manila, Philippines, 1015
    Completed
    Site US1008
    Tarrytown, NY, United States, 10591
    Withdrawn
    Site MX5202
    Mexico City, Mexico, 04530
    Withdrawn
    Site NL3101
    Nijmegen, Netherlands, 6525 GA
    Completed
    Site PL4801
    Warszawa, Poland, 04-730
    Withdrawn
    Site TR9005
    Istanbul, Turkey, 34890
    Withdrawn
    Site US1015
    Albany, NY, United States, 12208
    Completed
    Site DK4501
    Aarhus, Denmark, 8200
    Completed
    Site TR9003
    Ankara, Turkey, 6100
    Completed
    Site MX5203
    Leon, Mexico, 37000
    Withdrawn
    Site TR9004
    Kocaeli, Turkey, 41380
    Completed
    Site PL4803
    Gdansk, Poland, 80-952
    Withdrawn
    Site DE4901
    Marburg, Germany, 35043
    Withdrawn
    Site BR5501
    Santo André, São Paulo, Brazil, 09060-650

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?